. .
.
. Mayo Clinic Health Solutions
.
. .
.

Browse Categories:
  arrow Research Tools
arrow
  arrow Diagnostics
arrow
  arrow Therapeutics
arrow
  arrow Medical Devices
arrow
  arrow Electronic Devices
arrow
  arrow Software
arrow
  arrow All Listings
arrow
arrow
  Home
arrow
  About Us
arrow
  Contact Us
arrow
arrow
  Go to mayoclinic.org
arrow
  Go to Research at Mayo Clinic
arrow
Mayo Clinic Technology
.

ZAP-70-Deficient T-cell Activation Model

Reference #:

1997-035

Inventors/Contributors

Robert T. Abraham, Ph.D., Brandi L. Williams

Description

This technology is a T-cell line that lacks the protein tyrosine kinase, ZAP-70. ZAP-70 plays a critical role in the initiation of lymphocyte activation responses to antigenic stimuli. The cell line can be used to define the mechanisms of ZAP-70 activation and function in T-cell signaling. This line can be used also to confirm the mechanism of action of ZAP-70 targeted drugs. This is the first genetically manipulatable T-cell model system that lacks the critical protein tyrosine kinase, ZAP-70.

Patent Status

None

Contact

Julie A. Henry, Licensing Manager
henry.julie@mayo.edu

Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905

Phone: (507) 266-4585
Fax: (507) 284-5410